These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 407596)

  • 1. Perseveration and rotational behavior elicited by d-amphetamine in a Y-maze exploratory task: differential effects of intraperitoneal and unilateral intraventricular administration.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1977 Apr; 52(2):123-8. PubMed ID: 407596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine-elicited perseverative and rotational behavior: evaluation of directional preference.
    Kokkinidis L
    Pharmacol Biochem Behav; 1987 Mar; 26(3):527-32. PubMed ID: 3575367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abatement of stimulus perseveration following repeated d-amphetamine treatment: absence of behaviorally augmented tolerance.
    Kokkinidis L; Anisman H
    Pharmacol Biochem Behav; 1978 May; 8(5):557-63. PubMed ID: 566934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between cholinergic and catecholaminergic agents in a spontaneous alternation task.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1976 Aug; 48(3):261-70. PubMed ID: 823581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of d-amphetamine pellet implantation as a model for d-amphetamine tolerance in the mouse.
    Hitzemann RJ; Loh HH; Craves FB; Domino EF
    Psychopharmacologia; 1973 Jun; 30(3):227-40. PubMed ID: 4736782
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced responsiveness to intraventricular infusion of amphetamine following its repeated systemic administration.
    Rebec GV; Segal DS
    Psychopharmacology (Berl); 1979 Mar; 62(1):101-2. PubMed ID: 108743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic amphetamine treatment: differential modification of exploratory behavior in a radial maze.
    Bruto V; Anisman H
    Pharmacol Biochem Behav; 1983 Sep; 19(3):487-96. PubMed ID: 6634900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of d- and l-amphetamine on the open field performance of rats.
    Dandiya PC; Kulkarni SK
    Psychopharmacologia; 1974; 39(1):67-70. PubMed ID: 4472934
    [No Abstract]   [Full Text] [Related]  

  • 10. Dissociation of the effects of scopolamine and d-amphetamine on a spontaneous alternation task.
    Kokkinidis L; Anisman H
    Pharmacol Biochem Behav; 1976 Sep; 5(3):293-7. PubMed ID: 996062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased response switching, perseveration and perseverative switching following d-amphetamine in the rat.
    Evenden JL; Robbins TW
    Psychopharmacology (Berl); 1983; 80(1):67-73. PubMed ID: 6408674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of dose, novelty, and exploration on amphetamine-produced stereotyped behavior.
    Russell RL; Pihl RO
    Psychopharmacology (Berl); 1978 Dec; 60(1):93-100. PubMed ID: 104351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment.
    Bruto V; Beauchamp C; Zacharko RM; Anisman H
    Psychopharmacology (Berl); 1984; 83(1):62-9. PubMed ID: 6429702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of amphetamine elicited perseveration and locomotor excitation following acute and repeated stressor application.
    Hahn B; Zacharko RM; Anisman H
    Pharmacol Biochem Behav; 1986 Jul; 25(1):29-33. PubMed ID: 3749234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogenetic variations in amphetamine-induced stimulus perseveration.
    Kokkinidis L; Irwin J; Anisman H
    Behav Neural Biol; 1979 Jun; 26(2):221-33. PubMed ID: 573999
    [No Abstract]   [Full Text] [Related]  

  • 16. Some effects of prenatal exposure to d-amphetamine sulfate and phenobarbital on developmental neurochemistry and on behavior.
    Zemp JW; Middaugh LD
    Addict Dis; 1975; 2(1-2):307-31. PubMed ID: 1163369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stressor invoked exacerbation of amphetamine-elicited perseveration.
    Anisman H; Hahn B; Hoffman D; Zacharko RM
    Pharmacol Biochem Behav; 1985 Aug; 23(2):173-83. PubMed ID: 4059303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine behavioral toxicity: rotational behavior after chronic intrastriatal infusion.
    Dougherty GG; Ellinwood EH
    Biol Psychiatry; 1981 May; 16(5):479-88. PubMed ID: 7196774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats.
    Harkin A; Connor TJ; Mulrooney J; Kelly JP; Leonard BE
    Life Sci; 2001 Feb; 68(12):1367-82. PubMed ID: 11388689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance deficits of NK1 receptor knockout mice in the 5-choice serial reaction-time task: effects of d-amphetamine, stress and time of day.
    Yan TC; Dudley JA; Weir RK; Grabowska EM; Peña-Oliver Y; Ripley TL; Hunt SP; Stephens DN; Stanford SC
    PLoS One; 2011 Mar; 6(3):e17586. PubMed ID: 21408181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.